Technical Analysis for PRVB - Provention Bio, Inc.

Grade Last Price % Change Price Change
grade B 12.47 -4.66% -0.61
PRVB closed down 4.66 percent on Tuesday, February 25, 2020, on 77 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical PRVB trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -4.66%
MACD Bearish Centerline Cross Bearish -4.66%
Expansion Pivot Sell Setup Bearish Swing Setup -4.66%
BB Squeeze Ended Range Expansion -4.66%
Below Lower BB Weakness -4.66%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
Medicine Biopharmaceutical Medical Specialties Immunology Disease Diabetes Autoimmune Diseases Ulcerative Colitis Abdominal Pain Diarrhea Crohn's Disease Colitis Lupus Viral Diseases Immune Mediated Diseases

Is PRVB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.82
52 Week Low 2.2
Average Volume 657,914
200-Day Moving Average 10.21
50-Day Moving Average 14.71
20-Day Moving Average 15.11
10-Day Moving Average 14.77
Average True Range 1.01
ADX 20.91
+DI 15.44
-DI 32.18
Chandelier Exit (Long, 3 ATRs ) 14.34
Chandelier Exit (Short, 3 ATRs ) 15.37
Upper Bollinger Band 16.91
Lower Bollinger Band 13.30
Percent B (%b) -0.23
BandWidth 23.86
MACD Line -0.28
MACD Signal Line 0.07
MACD Histogram -0.3486
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.36
Resistance 3 (R3) 14.53 14.07 14.05
Resistance 2 (R2) 14.07 13.59 13.99 13.94
Resistance 1 (R1) 13.27 13.29 13.04 13.10 13.83
Pivot Point 12.81 12.81 12.70 12.73 12.81
Support 1 (S1) 12.01 12.33 11.78 11.84 11.11
Support 2 (S2) 11.55 12.03 11.47 11.00
Support 3 (S3) 10.75 11.55 10.90
Support 4 (S4) 10.58